15779565109_e09b063012_b_1

Fujifilm flu drug effective in treating coronavirus in Chinese clinical trials

March 18, 2020
Research and Development COVID-19, Wuhan Coronavirus, coronavirus

A flu drug has appeared to be effective in treating COVID-19, according to recent clinical trials in China. The drug, …

biogen_austria_238

100 coronavirus cases linked to Biogen-hosted event in Boston, State of Massachusetts confirms

March 18, 2020
Manufacturing and Production, Medical Communications, Research and Development Biogen, coronavirus, pharma

It is now known that around 100 of the known cases of the COVID-19 coronavirus can be traced to an …

shutterstock_273326141

$63bn Allergan/AbbVie merger review could be delayed by coronavirus

March 18, 2020
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, merger, pharma

The $63 billion merger of major pharma players AbbVie and Allergan could be facing hurdles on the road to regulatory …

gill-leng-380_x_215-1

NICE promotes Professor Gillian Leng as its new Chief Executive

March 18, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, pharma

NICE, the drug watchdog for the NHS in England and Wales, has announced that it has promoted Professor Gillian Leng …

shutterstock_206748499

New technologies and industry collaboration will help fight chronic illnesses

March 17, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, pharma

Authored by Dan Boot, Head of Digital Innovation at RB Health.Around the world, populations are aging. According to the World …

512px-ursula_von_der_leyen

European Commission offers €80m to CureVac to develop coronavirus vaccine

March 17, 2020
Manufacturing and Production, Research and Development, Sales and Marketing CureVac, EU, US, coronavirus

Following confirmation of reports that US President Donald Trump sought to persuade a biotech to provide US-exclusivity for a potential …

novo_nordisk_flag

Novo Nordisk halts three haemophilia studies after participants suffer thrombotic events

March 17, 2020
Manufacturing and Production, Research and Development Novo Nordisk, haemophilia, pharma

Novo Nordisk has moved to temporarily shut down two of its Phase 3 and one of its Phase 2 clinical …

astrazeneca_building_white

Success and failure at Phase 3 for AstraZeneca’s Imfinzi combos in first-line small cell lung cancer

March 17, 2020
Manufacturing and Production, Research and Development AstraZeneca, Cancer, Imfinzi, pharma

AstraZeneca has pulled back the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage …

FDA gives emergency authorisation to first coronavirus tests

March 17, 2020
Manufacturing and Production, Sales and Marketing FDA, Roche, US, coronavirus

The coronavirus crisis in the US has thus far been characterised by a lack of testing within its population. This …

moderna_norwood_plant

Human dosing begins for first US coronavirus vaccine

March 17, 2020
Manufacturing and Production, Research and Development Moderna, Vaccine, coronavirus, pharma

The race to develop a vaccine against the ongoing outbreak of novel coronavirus has stepped up with the news that …

anthony_mancini

Genmab announces newly-created Chief Financial Officer appointment

March 16, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genmab, pharma

Genmab has announced the establishment of the new position of Chief Operating Officer at the company, and has furthermore named …

trump_8566730507_2

Trump tried to solicit US-exclusivity for coronavirus vaccine, report claims

March 16, 2020
Sales and Marketing CureVac, Trump, US, coronavirus, pharma

President Trump has attracted criticism from all sides over his response to the novel coronavirus outbreak; after repeatedly downplaying the …

shutterstock_159488225

Bavencio Phase 3 head and neck cancer trial terminated

March 16, 2020
Research and Development, Sales and Marketing Bavencio, Cancer, EMD Serono, Merck KGaA, Pfizer, trial failure

Merck KGaA, its biopharma division EMD Serono, and Pfizer have announced their decision to terminate their ongoing Phase 3 trial …

prep

NHS England to supply HIV prevention drug PrEP with £16m government investment

March 16, 2020
Manufacturing and Production, Sales and Marketing NHS, NHS England, PrEP HIV, PrEP< HIV, UK, pharma

NHS England is set to fund the availability of pre-exposure prophylaxis (PrEP) for the prevention of HIV for local authorities …

shutterstock

Fosun and BioNTech partner up for coronavirus vaccine development and commercialisation

March 16, 2020
Research and Development, Sales and Marketing BioNTech, coronavirus, fosun, pharma

As the novel coronavirus (COVID-19) outbreak continues to test global leadership, a new partnership has been announced between BioNTech and …

celltrion1

FDA greenlights Celltrion HIV drug manufacturing facility in South Korea

March 16, 2020
Manufacturing and Production, Sales and Marketing FDA, celltrion, coronavirus, pharma

South Korean biopharma firm Celltrion has revealed that one of its key manufacturing facilities has been given the all-clear by …

5378943799_deb47ba367_b

Numerous sporting events suspended across the UK, after staff and players test positive for COVID-19

March 13, 2020
Medical Communications Chinese Coronavirus, UK Coronavirus, Wuhan Coronavirus, coronavirus

Sporting events across the UK have been postponed as measures are taken to halt the spread of the coronavirus. Rugby …

shutterstock_38078521

AstraZeneca’s cediranib combo misses main goal in platinum-sensitive relapsed ovarian cancer

March 13, 2020
Medical Communications, Research and Development AstraZeneca, cediranib, lynparza, pharma, trial failure

Newly revealed Phase 3 data has shown that AstraZeneca’s oral vascular endothelial growth factor receptor (VEGFR) inhibitor cediranib, when combined …

Venclyxto combo scores European approval for previously untreated chronic lymphocytic leukaemia

March 13, 2020
Medical Communications, Sales and Marketing AbbVie, European Commission, Roche, Venclyxto, pharma

The European Commission has moved to authorise AbbVie and Roche’s B-cell lymphoma-2 (BCL-2) inhibitor Venclyxto (venetoclax) when used in combination …

The Gateway to Local Adoption Series

Latest content